Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Rhythm Biosciences Limited
  6. Summary
    RHY   AU000000RHY2

RHYTHM BIOSCIENCES LIMITED

(RHY)
  Report
Delayed Australian Stock Exchange  -  12:49 2022-10-07 am EDT
1.210 AUD   -1.63%
09/09Rhythm Biosciences Chair Sells Shares to Domestic Fund Manager
MT
08/29Rhythm Biosciences Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
07/19Rhythm Biosciences Completes Initial Biomarker Review for Core Cancer Detection Technology
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsFunds 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
10/03/2022 10/04/2022 10/05/2022 10/06/2022 10/07/2022 Date
1.23(c) 1.225(c) 1.2(c) 1.23(c) 1.21(c) Last
46 301 94 428 162 612 642 374 135 894 Volume
-1.60% -0.41% -2.04% +2.50% -1.63% Change
More quotes
Estimated financial data (e)
Sales 2021 1,11 M 0,71 M 0,71 M
Net income 2021 -6,61 M -4,23 M -4,23 M
Net cash position 2021 2,27 M 1,45 M 1,45 M
P/E ratio 2021 -24,8x
Yield 2021 -
Sales 2022 2,43 M 1,55 M 1,55 M
Net income 2022 -8,79 M -5,62 M -5,62 M
Net cash position 2022 7,43 M 4,75 M 4,75 M
P/E ratio 2022 -27,4x
Yield 2022 -
Capitalization 262 M 168 M 168 M
EV / Sales 2021 159x
EV / Sales 2022 98,4x
Nbr of Employees -
Free-Float 66,4%
More Financials
Company
Rhythm Biosciences Limited is a medical diagnostics technology company. The Company is engaged in developing and commercializing Australian medical diagnostics technology for sale in domestic and international markets. The Company’s development stage product, ColoSTAT focuses on providing early detection testing for colorectal cancer. The Company’s ColoSTAT blood test is used to detect colorectal cancer at all... 
More about the company
All news about RHYTHM BIOSCIENCES LIMITED
09/09Rhythm Biosciences Chair Sells Shares to Domestic Fund Manager
MT
08/29Rhythm Biosciences Limited Reports Earnings Results for the Full Year Ended June 30, 20..
CI
07/19Rhythm Biosciences Completes Initial Biomarker Review for Core Cancer Detection Technol..
MT
07/18Rhythm Biosciences Limited Advances Platform Expansion with Other Cancers
CI
06/19Rhythm Biosciences : Application for quotation of securities - RHY
PU
05/12Rhythm Biosciences Files Listing for Colorectal Cancer Diagnostic Test
MT
05/03Rhythm Biosciences Closes Last Trial Site for Colorectal Cancer Study
MT
05/03Rhythm Biosciences Limited Closes Final Clinical Trial Site
CI
04/26Rhythm Biosciences : Application for quotation of securities - RHY
PU
04/11Rhythm Biosciences : Application for quotation of securities - RHY
PU
04/06Rhythm Biosciences : Application for quotation of securities - RHY
PU
04/05Rhythm Biosciences : RHY Presentation at PAC Partners Healthcare Conference
PU
04/04Rhythm Biosciences : Investor Presentation
PU
04/04Rhythm Biosciences Meets Primary Endpoint in Accuracy Trial for Cancer Diagnostic Kit; ..
MT
04/03Rhythm Biosciences Announces the Statistical Analysis Outcomes of Its Clinical Trial (S..
CI
More news
News in other languages on RHYTHM BIOSCIENCES LIMITED
09/09Le président de Rhythm Biosciences vend des actions à un gestionnaire de fonds national
08/29Rhythm Biosciences Limited annonce ses résultats pour l'exercice complet clos le 30 jui..
07/19Rhythm Biosciences achève l'examen initial des biomarqueurs pour sa technologie princip..
07/18Rhythm Biosciences Limited poursuit l'expansion de sa plateforme avec d'autres cancers
05/03Rhythm Biosciences Limited ferme le dernier site d'essai clinique
More news
Chart RHYTHM BIOSCIENCES LIMITED
Duration : Period :
Rhythm Biosciences Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RHYTHM BIOSCIENCES LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
Glenn Gilbert Managing Director & Director
Otto Leslie Steven Buttula Executive Chairman
Trevor John Lockett Executive Director & Technical Director
Rachel David Independent Non-Executive Director
Louis James Panaccio Non-Executive Director
Sector and Competitors